Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1989 Mar;57(3):882–886. doi: 10.1128/iai.57.3.882-886.1989

Pseudomonas aeruginosa cytotoxin: periplasmic localization and inhibition of macrophages.

J L Kluftinger 1, F Lutz 1, R E Hancock 1
PMCID: PMC313193  PMID: 2492976

Abstract

Pseudomonas aeruginosa cytotoxin has been isolated previously from cell autolysates. Both purified cytotoxin and periplasmic contents (osmotic shock fluid) cross-reacted on Western immunoblots with antibodies specific for cytotoxin. In addition, both preparations caused a significant reduction in antibody-mediated phagocytosis of P. aeruginosa M2 by mouse macrophage cell line P388D1. Phagocytosis was restored in each case on preincubation of cytotoxin or periplasmic contents with anti-cytotoxin serum. Both cytotoxin and periplasmic contents caused depolarization of the P388D1 cell membrane, as demonstrated with a polarization-sensitive fluorescent probe. Similar correlations were not observed for other P. aeruginosa cell fractions or for osmotic shock fluid from Escherichia coli C600. These data indicate that P. aeruginosa cytotoxin is localized in the periplasm and has the potential to inhibit macrophage-mediated phagocytosis, possibly by perturbing ion gradients across the macrophage plasma membrane.

Full text

PDF
882

Images in this article

884Image
on p.884

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appleyard R K. Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12. Genetics. 1954 Jul;39(4):440–452. doi: 10.1093/genetics/39.4.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baltch A. L., Hammer M. C., Smith R. P., Obrig T. G., Conroy J. V., Bishop M. B., Egy M. A., Lutz F. Effects of Pseudomonas aeruginosa cytotoxin on human serum and granulocytes and their microbicidal, phagocytic, and chemotactic functions. Infect Immun. 1985 May;48(2):498–506. doi: 10.1128/iai.48.2.498-506.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baltch A. L., Obrig T. G., Smith R. P., Hammer M. C., Conroy J. V., Lutz F. Production of cytotoxin by clinical strains of Pseudomonas aeruginosa. Can J Microbiol. 1987 Feb;33(2):104–111. doi: 10.1139/m87-018. [DOI] [PubMed] [Google Scholar]
  4. Battershill J. L., Speert D. P., Hancock R. E. Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages. Infect Immun. 1987 Oct;55(10):2531–2533. doi: 10.1128/iai.55.10.2531-2533.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Donohue-Rolfe A., Keusch G. T. Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock. Infect Immun. 1983 Jan;39(1):270–274. doi: 10.1128/iai.39.1.270-274.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dunn D. L., Barke R. A., Knight N. B., Humphrey E. W., Simmons R. L. Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun. 1985 Aug;49(2):257–264. doi: 10.1128/iai.49.2.257-264.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Evans D. J., Evans D. G., Gorbach S. L. Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun. 1974 Nov;10(5):1010–1017. doi: 10.1128/iai.10.5.1010-1017.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gilleland H. E., Jr, Stinnett J. D., Eagon R. G. Ultrastructural and chemical alteration of the cell envelope of Pseudomonas aeruginosa, associated with resistance to ethylenediaminetetraacetate resulting from growth in a Mg2+-deficient medium. J Bacteriol. 1974 Jan;117(1):302–311. doi: 10.1128/jb.117.1.302-311.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hancock R. E., Carey A. M. Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins. J Bacteriol. 1979 Dec;140(3):902–910. doi: 10.1128/jb.140.3.902-910.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hancock R. E., Nikaido H. Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol. 1978 Oct;136(1):381–390. doi: 10.1128/jb.136.1.381-390.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harboe N., Ingild A. Immunization, isolation of immunoglobulins, estimation of antibody titre. Scand J Immunol Suppl. 1973;1:161–164. doi: 10.1111/j.1365-3083.1973.tb03798.x. [DOI] [PubMed] [Google Scholar]
  12. Hoshino T., Kageyama M. Purification and properties of a binding protein for branched-chain amino acids in Pseudomonas aeruginosa. J Bacteriol. 1980 Mar;141(3):1055–1063. doi: 10.1128/jb.141.3.1055-1063.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Karmali M. A., Petric M., Lim C., Cheung R., Arbus G. S. Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol. 1985 Oct;22(4):614–619. doi: 10.1128/jcm.22.4.614-619.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kropinski A. M., Kuzio J., Angus B. L., Hancock R. E. Chemical and chromatographic analysis of lipopolysaccharide from an antibiotic-supersusceptible mutant of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1982 Feb;21(2):310–319. doi: 10.1128/aac.21.2.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lutz F., Maurer M., Failing K. Cytotoxic protein from Pseudomonas aeruginosa: formation of hydrophilic pores in Ehrlich ascites tumor cells and effect on cell viability. Toxicon. 1987;25(3):293–305. doi: 10.1016/0041-0101(87)90258-3. [DOI] [PubMed] [Google Scholar]
  16. Lutz F. Purification of a cytotoxic protein from Pseudomonas aeruginosa. Toxicon. 1979;17(5):467–475. doi: 10.1016/0041-0101(79)90280-0. [DOI] [PubMed] [Google Scholar]
  17. Mutharia L. M., Hancock R. E. Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies. Infect Immun. 1983 Dec;42(3):1027–1033. doi: 10.1128/iai.42.3.1027-1033.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Neu H. C., Heppel L. A. The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J Biol Chem. 1965 Sep;240(9):3685–3692. [PubMed] [Google Scholar]
  19. Nicas T. I., Hancock R. E. Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J Bacteriol. 1980 Aug;143(2):872–878. doi: 10.1128/jb.143.2.872-878.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nowakowski M., Edelson P. J., Bianco C. Activation of C3H/HeJ macrophages by endotoxin. J Immunol. 1980 Nov;125(5):2189–2194. [PubMed] [Google Scholar]
  21. Poole K., Hancock R. E. Phosphate transport in Pseudomonas aeruginosa. Involvement of a periplasmic phosphate-binding protein. Eur J Biochem. 1984 Nov 2;144(3):607–612. doi: 10.1111/j.1432-1033.1984.tb08508.x. [DOI] [PubMed] [Google Scholar]
  22. Reynolds H. Y., Kazmierowski J. A., Newball H. H. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages. J Clin Invest. 1975 Aug;56(2):376–385. doi: 10.1172/JCI108102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rink T. J., Montecucco C., Hesketh T. R., Tsien R. Y. Lymphocyte membrane potential assessed with fluorescent probes. Biochim Biophys Acta. 1980;595(1):15–30. doi: 10.1016/0005-2736(80)90243-6. [DOI] [PubMed] [Google Scholar]
  24. Sasaki T., Lutz F. Action of a cytotoxin from Pseudomonas aeruginosa on human leukemic cell lines. Increase in cell permeability to Ca2+ and Mn2+ and lack of stimulation of inositol lipid turnover. FEBS Lett. 1985 Sep 9;189(1):33–36. doi: 10.1016/0014-5793(85)80836-x. [DOI] [PubMed] [Google Scholar]
  25. Scharmann W. Cytotoxic effects of leukocidin from Pseudomonas aeruginosa on polymorphonuclear leukocytes from cattle. Infect Immun. 1976 Mar;13(3):836–843. doi: 10.1128/iai.13.3.836-843.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Scharmann W. Formation and isolation of leucocidin from Pseudomonas aeruginosa. J Gen Microbiol. 1976 Apr;93(2):283–291. doi: 10.1099/00221287-93-2-283. [DOI] [PubMed] [Google Scholar]
  27. Speert D. P. Host defenses in patients with cystic fibrosis: modulation by Pseudomonas aeruginosa. Surv Synth Pathol Res. 1985;4(1):14–33. doi: 10.1159/000156962. [DOI] [PubMed] [Google Scholar]
  28. Stieritz D. D., Holder I. A. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J Infect Dis. 1975 Jun;131(6):688–691. doi: 10.1093/infdis/131.6.688. [DOI] [PubMed] [Google Scholar]
  29. Suttorp N., Seeger W., Uhl J., Lutz F., Roka L. Pseudomonas aeruginosa cytotoxin stimulates prostacyclin production in cultured pulmonary artery endothelial cells: membrane attack and calcium influx. J Cell Physiol. 1985 Apr;123(1):64–72. doi: 10.1002/jcp.1041230111. [DOI] [PubMed] [Google Scholar]
  30. Young J. D., Ko S. S., Cohn Z. A. The increase in intracellular free calcium associated with IgG gamma 2b/gamma 1 Fc receptor-ligand interactions: role in phagocytosis. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5430–5434. doi: 10.1073/pnas.81.17.5430. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES